Evidence map›Paper›PMID 42198963›Full record

Trial reportNan fang yi ke da xue xue bao = Journal of Southern Medical University2026

[

Yuanyuan Cheng, Chuanbing Huang, Juan Zhang, Yawen Zhu, Ai Qian

Abstract readRandomized Controlled TrialEnglish Abstract
In one paragraph

Trial report in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuanyuan ChengFirst Clinical College, Anhui University of Chinese Medicine, Hefei 230000, China.
Chuanbing HuangDepartment of Rheumatology and Immunology.
Juan ZhangDepartment of Neurology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China.
Yawen ZhuFirst Clinical College, Anhui University of Chinese Medicine, Hefei 230000, China.
Ai QianFirst Clinical College, Anhui University of Chinese Medicine, Hefei 230000, China.

Funding

National Natural Science Foundation of China 82104782
6 · The paper itself

Abstract

objectivesTo explore the mechanism mediating the ameliorative effect of

methodsBioinformatics approaches were used for analyzing the active ingredients of

resultsFour key active ingredients (quercetin, eupatilin, kaempferol, and wogonin) of

conclusions

Indexed as

Drugs, Chinese HerbalNF-E2-Related Factor 2Osteoarthritis, KneeCartilage, ArticularFemaleFerroptosisHumansMaleMiddle AgedMolecular Docking SimulationSignal TransductionDrugs, Chinese HerbalNFE2L2 protein, humanNF-E2-Related Factor 2chondrocytesChonggu Granulesferroptosisknee osteoarthritisnetwork pharmacology

Identifiers

PMID42198963
PMCPMC13213366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.